Ventas, Inc. $VTR Shares Purchased by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd raised its holdings in Ventas, Inc. (NYSE:VTR) by 28.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,524 shares of the real estate investment trust’s stock after buying an additional 18,527 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Ventas were worth $5,846,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Ventas by 4.1% in the 2nd quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock valued at $4,533,937,000 after purchasing an additional 2,854,751 shares during the last quarter. State Street Corp lifted its stake in shares of Ventas by 5.2% in the 2nd quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock valued at $1,781,267,000 after purchasing an additional 1,388,678 shares in the last quarter. Geode Capital Management LLC raised its holdings in Ventas by 4.9% in the second quarter. Geode Capital Management LLC now owns 12,226,283 shares of the real estate investment trust’s stock valued at $769,061,000 after buying an additional 574,663 shares during the period. Charles Schwab Investment Management Inc. grew its stake in Ventas by 6.3% during the second quarter. Charles Schwab Investment Management Inc. now owns 5,597,778 shares of the real estate investment trust’s stock worth $353,500,000 after buying an additional 331,477 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its holdings in shares of Ventas by 1.0% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 5,570,471 shares of the real estate investment trust’s stock valued at $351,775,000 after acquiring an additional 53,614 shares in the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Ventas Trading Up 0.5%

NYSE:VTR opened at $76.94 on Friday. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. The business’s 50 day moving average is $78.51 and its two-hundred day moving average is $72.36. Ventas, Inc. has a 52 week low of $58.72 and a 52 week high of $81.89. The company has a market cap of $36.14 billion, a PE ratio of 147.95, a P/E/G ratio of 1.91 and a beta of 0.78.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.01. The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.44 billion. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The business’s quarterly revenue was up 20.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.80 EPS. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. On average, analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, January 15th. Shareholders of record on Wednesday, December 31st were paid a dividend of $0.48 per share. The ex-dividend date was Wednesday, December 31st. This represents a $1.92 annualized dividend and a yield of 2.5%. Ventas’s payout ratio is presently 369.23%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Jefferies Financial Group reiterated a “buy” rating and issued a $93.00 target price on shares of Ventas in a research note on Monday, December 15th. Wells Fargo & Company upped their price objective on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. The Goldman Sachs Group began coverage on Ventas in a research note on Friday, January 9th. They issued a “buy” rating and a $94.00 price target on the stock. KeyCorp raised their price objective on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Finally, Citigroup upped their target price on Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $81.63.

Insiders Place Their Bets

In other news, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.26, for a total value of $797,477.72. Following the transaction, the chief executive officer directly owned 1,145,695 shares in the company, valued at approximately $88,516,395.70. This trade represents a 0.89% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Peter J. Bulgarelli sold 2,229 shares of Ventas stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $80.08, for a total transaction of $178,498.32. Following the completion of the transaction, the chief executive officer directly owned 106,488 shares of the company’s stock, valued at $8,527,559.04. This trade represents a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 494,005 shares of company stock valued at $37,132,767. Company insiders own 0.80% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.